Skip to main content

Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) Investor Investigation Over Potential Breaches Of Fiduciary Duties In Connection With The Proposed Takeover By Bristol-Myers Squibb

  • If you purchased shares of Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) prior to June 29, 2012, and currently hold any of those NASDAQ:AMLN shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

July 2, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) shares was announced concerning whether the offer to acquire Amylin Pharmaceuticals, Inc. at $31 per NASDAQ:AMLN shares and the takeover process are unfair to investors in NASDAQ:AMLN shares. The investigation by a law firm concerns whether certain officers a...

You must register (for free) or login to view the entire investigation.